On the bright side: A vaccine and Joe Biden in one week

Chloe McCulloch

Now construction just needs investors to press ahead with projects and government to commit to long-term funding

“A great day for science and humanity … ” At last, there was some positive news this week of vaccine trials, with Pfizer and BioNTech announcing a success rate that exceeded all expectations, preventing 90% of people from contracting covid-19. There is now a real prospect that some kind of normality will return in the spring.

Aside from the amazing speed at which an apparently effective vaccine has been developed, the timing of the announcement in the first week of England’s second nationwide lockdown has meant the sense of relief and hope has been hard to contain.

But the point for business is that scientists have proved that it should be possible to control the disease, thereby ending the prospect of a continuing cycle of lockdowns and restrictions that curtail key parts of the economy. Construction is able to operate during the second lockdown, although for key sectors it works in, such as retail and leisure, building work is the last thing they need.

Already registered? Login here

To continue enjoying Building.co.uk, sign up for free guest access

Existing subscriber? LOGIN

 

Stay at the forefront of thought leadership with news and analysis from award-winning journalists. Enjoy company features, CEO interviews, architectural reviews, technical project know-how and the latest innovations.

  • Limited access to building.co.uk
  • Breaking industry news as it happens
  • Breaking, daily and weekly e-newsletters

Get your free guest access  SIGN UP TODAY

Gated access promo

Subscribe now for unlimited access

 

Subscribe to Building today and you will benefit from:

  • Unlimited access to all stories including expert analysis and comment from industry leaders
  • Our league tables, cost models and economics data
  • Our online archive of over 10,000 articles
  • Building magazine digital editions
  • Building magazine print editions
  • Printed/digital supplements

Subscribe now for unlimited access.

View our subscription options and join our community